Transcript
Page 1: Thyroid hormones: Clinical and Biochemical Insight

Thyroid Hormones :Clinical and Biochemical Insight

Dr. Abhishek Roy

JR-II, Dept. of Biochemistry,

Grant Govt. Medical College &

Sir J.J. Group of Hospitals, Mumbai

Email: [email protected]

Date: 15/07/2014

Page 2: Thyroid hormones: Clinical and Biochemical Insight

Dealing with the topic

• Functions

• Biochemistry

• Physiology

• Radiographic Thyroid Testing

• Analytical Methods of the various thyroid hormones

• Clinical Correlations

Page 3: Thyroid hormones: Clinical and Biochemical Insight

Functions of Thyroid Hormones

• Increase O2 consumption within tissues via increased membrane transport.(More ATP consumed and more Na+-K+ ATPase function)

• Enhanced mitochondrial metabolism

• Increased sensitivity to catecholamines

• Stimulate protein synthesis and carbohydrate metabolism

• Increased synthesis and degradation of cholesterol and triglycerides.

• Increased Vitamin requirements

• Regulate Calcium and Phosphorus metabolism.

Page 4: Thyroid hormones: Clinical and Biochemical Insight

BIOCHEMISTRY OF THE HORMONES

• rT3- 3,3’,5’-L-triiodothyronine

• T3- 3,5,3’-L-triiodothyronine

• T4- tetraiodothyronine(Thyroxine)

• MIT- Monoiodotyrosine

• DIT- Diiodotyrosine

Page 5: Thyroid hormones: Clinical and Biochemical Insight
Page 6: Thyroid hormones: Clinical and Biochemical Insight
Page 7: Thyroid hormones: Clinical and Biochemical Insight

Peripheral conversion of T4 to T3 and rT3

Page 8: Thyroid hormones: Clinical and Biochemical Insight
Page 9: Thyroid hormones: Clinical and Biochemical Insight
Page 10: Thyroid hormones: Clinical and Biochemical Insight
Page 11: Thyroid hormones: Clinical and Biochemical Insight
Page 12: Thyroid hormones: Clinical and Biochemical Insight

Thyroid Hormone Receptor Sizes

Amino Acids kDa

• TRα1 410 47

• TRα2 490 55

• TRβ1 461 53

• TRβ2 514 58

• TRβ is encoded by 11 exons on THRB gene on chromosome 3p24.3.

• Three isoforms of TRβ exist: TRβ1, TRβ2, TRβ3

• TRβ1 found in Heart, Kidney, Liver and Brain.

• TRβ2 found in Adenohypophysis, Retina, Cochlea and Developing Brain.

• Defects in TRβ1 can produce resistance to thyroid hormone.

• Defects in TRα is not been reported.

Page 13: Thyroid hormones: Clinical and Biochemical Insight

The log-linear relationship between TSH and FT4. A two fold change in TSH is associated with

approx. 100-fold change in circulating FT4 concentration.

Page 14: Thyroid hormones: Clinical and Biochemical Insight

Thyroid Hormones in Circulation

• TBP TBG TTR Albumin

• Concentration 4-5.4 µg/dL 10-20 µg/dL 3.5-5 g/dL

• Affinity for T4 High Modest Low

• T4 capacity, µ/dL 22 120 1000

• Distribution

• T4 67% 20% 13%

• T3 53% 1% 46%

Page 15: Thyroid hormones: Clinical and Biochemical Insight

Salient Points

• Protein Bound T4 and T3 serve as thyroid hormone reservoirs within plasma.

• FT4 concentrations correlate more closely to clinical status of the patients than total T4 conc.

• Low FT3 do not always correlate with clinical hypothyroidism as evidenced in sick euthyroid syndrome.

• Similarly elevated FT4 and FT3 don’t always correlate with hyperthyroidism coz of possibility of peripheral thyroid hormones resistance syndrome and rare MCT8 loss of function mutations.

Page 16: Thyroid hormones: Clinical and Biochemical Insight

Thyroid Hormone Physiology

Page 17: Thyroid hormones: Clinical and Biochemical Insight

Thyrotropin Releasing Hormone

TRH is a tripeptide (L-pyroglutamyl-L-histidyl-L-prolinamide)

Page 18: Thyroid hormones: Clinical and Biochemical Insight

Radioiodine uptake (RAIU)

• Radioactive iodine(I123 or I131) or 99mTc-pertechnetate

• Reference interval is usually 5 to 25% in 24hrs.

• In most endogenous hyperthyroid states the RAIU is

• In hypothyroid, RAIU is decreased.

• In thyrotoxicosis, measurement of peak at 6hrs seen.

• Anatomic disorders:

• Hemithyroid (toxic hyperthyroid nodule)

• Cold nodule

• Ectopic thyroid

Page 19: Thyroid hormones: Clinical and Biochemical Insight

Worldwide Distribution of Iodine Nutrition

Page 20: Thyroid hormones: Clinical and Biochemical Insight

Comparison of T4 and T3 ( properties)

Page 21: Thyroid hormones: Clinical and Biochemical Insight

MOA of Thyroid Hormones

Page 22: Thyroid hormones: Clinical and Biochemical Insight

Analytical Methodology

•Principal Of Chemiluminescence

•Direct Methods

•Indirect Methods

Page 23: Thyroid hormones: Clinical and Biochemical Insight

Chemiluminescence

• Emission of light when an electron returns to a lower energy level from a higher energy level.

• The excitation is caused by oxidation of organic compound such as luminol, isoluminol, acridinium esters or luciferin by an oxidant like H2O2, HOCl-, O2

• Reaction accurs in presence of catalyst enzymes( Alkaline Phosphatase, Horse radish Peroxidase, Microperoxidase), metal ions etc.

• Ultrasensitive assays- 10-18 to 10-21

Page 24: Thyroid hormones: Clinical and Biochemical Insight
Page 25: Thyroid hormones: Clinical and Biochemical Insight
Page 26: Thyroid hormones: Clinical and Biochemical Insight
Page 27: Thyroid hormones: Clinical and Biochemical Insight

Sample collection and storage:

• For all hormonal parameters done in J.J. Hospitals, Mumbai with the use of IMMULITE 1000 Immunoassay( Chemiluminescence):

• Sample is collected in Plain vaccutainers or Plain Bulb.

• The samples are centrifuged at around 2500-4000 rpm for 2-3 mins.

• The serum can stored at 2-8ºC maximum for 7 days and when stored at ―20ºC it can be stored for 2 months.

Page 28: Thyroid hormones: Clinical and Biochemical Insight

Determination of TSH

• Immunoassay is the method of choice.

• We use Immulite 1000 Rapid TSH kit with incubation cycle of 1 X 30 mins.

• Volume required: 75 µL (Sample = 100 µL more)

• Analytical Sensitivity: 0.01 µIU/mL

• Callibration Range: 75 µIU/mL

• Euthyroid: 0.4-4 µIU/mL

• True Hyperthyroidism: <0.01 µIU/mL

• Secretion of TSH is in circadian fashion:• Highest between 2:00 am to 4:00 am

• Lowest between 5:00 pm to 6:00 pm

• Low amplitude oscillations occur throughout the day.

• TSH surges immediately after birth to around 25-160 µIU/mL

• Reach back to cord blood levels by 3 days and then to adult value by 7 days.

Page 29: Thyroid hormones: Clinical and Biochemical Insight

Determination of Thyroxine (Total T4)

• Immunoassays measure both free and bound form.

• Therefore dissociation is required as 99.97% of T4 is bound to TBG, TBPA and Albumin.

• Volume required: 15 µL(Sample = 100 µL more)

• Incubation cycles: 1 X 30 mins

• Association constant:• T4 to Albumin: ~1.6 X 106 L/mol• T4 to TBG: ~2 X 1010 L/mol• T4 to TBPA: ~2 X 108 L/mol• T4 to Antibody in test: ~109 L/mol

• Association Broken by:• T4 to TBPA: Barbital Buffers as they do this selectively.• T4 to TBG: Agent of choice is 8-anilino-1-naphthalene-sulfonic (ANS) acid.

Page 30: Thyroid hormones: Clinical and Biochemical Insight

• Normal Range: 4.5-12.5 µg/dL

• Calibration range: 1.0-24 µg/dL

• Analytical Sensitivity: 0.4 µg/dL

• At birth, serum total T4 are higher in neonatal period

because of maternal estrogen-induced increase in serum

TBG while FT4 values are near adult concentrations.

• Total T4 values rie abruptly in the firsts few hours after

birth and decline gradually until the age of 15 yrs.

Page 31: Thyroid hormones: Clinical and Biochemical Insight

Determination of Triiodothyronine (Total T3)

• Antiserum has been produced using T3 enriched Tg, T3-human serum albumin (HAS) or T3-bovine serum albumin (BSA) conjugates.

• Monoclonal T3 antibodies have also been produced using hybridomatechnique.

• Method of choice now is Chemiluminescence.

• Levels of T3 depends on age.

• Volume required: 25 µL( Sample = 100 µL more)

• Normal Range: 81-178ng/dL

• Analytical sensitivity: 35 ng/dL

• Calibration range: 40-600 ng/dL

Page 32: Thyroid hormones: Clinical and Biochemical Insight

Determination of reverse Triiodothyronine (rT3)

• It’s a biologically inert and is a catabolite of T4.

• rT3 estimation is usually not required clinically, hence generally hospital labs refer this to other large reference labs.

• In J.J. Hospitals, rT3 is not done.

• Formed by 5´-deiodinases when acting on T4 peripherally.

Page 33: Thyroid hormones: Clinical and Biochemical Insight

Determination of Free Thyroid Hormones

• Technical challenge as FT4 is 0.03% and FT3 is 0.3% of T4 & T3.

• Most reliable methods are:• Direct Equilibrium Dialysis

• Ultrafiltration

• These are extremely time consuming and hence have been replaced by Chemiluminescence for all practical purposes.

Page 34: Thyroid hormones: Clinical and Biochemical Insight

Direct Equilibrium Dialysis

• Undiluted serum samples are dialyzed for 16 to 18 hrs at 37ºC in a reusable dialysis chamber.

• Dialysis buffer provides for minimal changes in the serum matrix

• Dialysate is then analyzed directly using a sensitive (RIA).

• The range of expected results is 2 to 128 ng/L.

• Interassay CV is <10%.

Page 35: Thyroid hormones: Clinical and Biochemical Insight

Ultrafiltration

• Significantly less time consuming.

• Serum specimen is adjusted to a pH of 7.4.

• Then incubated for 20 mins at 37ºC.

• Applied to an ultracentrifugation device for 30 mins at 37ºC and 2000 X g.

• Later ultrafiltrate is analyzed for T4 by immunoassay.

Page 36: Thyroid hormones: Clinical and Biochemical Insight

Indirect methods for Free Thyroid Hormones

• In these methods, the basic principle is Estimation of FT4 and FT3 by antibody extraction techniques.

• Two Step Immunoassays:• The free hormones is made to react with solid phase antibodies and the other serum protein

bound hormones are washed away.

• Tracer(labelled) T4 & T3 is made to react with the left over antibodies(back titration).

• The quantity of bound tracer then is compared with calibration curve generated from secondary calibrators that have had target values assigned to them by reference method.

• One step Immunoassays:• Unlike two step methods, analogue assays rely on simultaneous rather than sequential back

titration of unoccupied antibody binding sites.

Page 37: Thyroid hormones: Clinical and Biochemical Insight

FT4 through Chemiluminescence

• Ranges:• Euthyroid: 0.89-1.76 ng/dL

• Hypothyroid: <0.89 ng/dL

• Hyperthyroid: >1.76 ng/dL

• Reportable range: 0.3-6 ng/dL

• Volume required: 10 µL ( Sample = 100 µL more)

• Analytical Sensitivity: 0.13 ng/dL (Limit of Blank)

• Functional Sensitivity: 0.30 ng/dL(conc. with 20% CV)

• Incubation Cycles: 1 X 30 mins (Time to first result: 42 mins)

Page 38: Thyroid hormones: Clinical and Biochemical Insight

FT3 through Chemiluminescence

• Normal Range: 1.5-4.1 pg/mL

• Calibration range: 1-40 pg/mL

• Analytical Sensitivity: 1.0 pg/mL

• Incubation cycles: 2 X 30 mins

• Volume required: 100 µL (Sample = 250 µL more)

Page 39: Thyroid hormones: Clinical and Biochemical Insight

Clinical Correlations

Page 40: Thyroid hormones: Clinical and Biochemical Insight

Thyroid Stimulating Hormone (TSH)

• In Primary Hypothyroidism: TSH levels are typically high

• In secondary and tertiary hypothyroidism: TSH levels low.

• In Primary Hyperthyroidism: TSH levels are very low

• In Secondary and tertiary hyperthyroidism: TSH levels are very high.

• Measurement of circulating TSH has been used as a primary test for DD of Hypothyroidism and as an aid in monitoring hormone replacement therapy.

• TSH >2.0 µIU/mL have increased risk to develop thyroid diseases in next 20yrs.

Page 41: Thyroid hormones: Clinical and Biochemical Insight

Total Thyroxine (Total T4)

• Hyperthyroidism: Increased

• Hypothyroidism: Decreased

• Elevated T4 levels may be seen when TBG levels are high as in pregnancy, Acute intermittent porphyria, hyperproteinemia, hereditary TBG elevation, pts. Undergoing estrogen therapy or taking OCPs.

• Total T4 levels are low when TBG is low as in Nephrotic, Hepatic, Gastrointestinal and neoplastic disorders, acromegaly, hypoproteinemia, hereditary TBG deficiency, pts. Undergoing androgen, testosterone or anabolic steroid therapy.

• Diphenylhydantoin and large doses of salicylates and liothyroninemay also cause low T4 values (Competition for binding TBG)

Page 42: Thyroid hormones: Clinical and Biochemical Insight

Total Triiodothyronine (Total T3)

• T3 represents approx. 5% of total thyroid hormones in system

• T3 has greater intrinsic metabolic activity, faster turnover and larger volume of distribution than circulating T4.

• Reports do suggest that thyrotoxicosis may be caused by abnormally high conc. of T3 rather than T4.

• T3- Imp. Tool for monitoring patients receiving sodium liothyroninetherapy.

• Reports suggest, T3 can differentiate well between Euthyroid and Hyperthyroid but provide a less clear-cut separation between hypothyroid and euthyroid subjects.

Page 43: Thyroid hormones: Clinical and Biochemical Insight

Free Thyroxine (FT4)

• Altered TBG result in false T4 levels and FT4 often remain under a very tight range.

• For this reason Total T4 do not always reflect the thyroid status.

• Total T4 levels even though increased, the FT4 levels may be normal.

• Alternatively, patients with dysfunctional thyroid gland and altered TBG levels can have normal total T4 levels masking the illness.

• Therefore its FT4 that highly correlate with clinical scenario.

Page 44: Thyroid hormones: Clinical and Biochemical Insight

Free Triiodothyronine (FT3)

• Free T3 conc. Constitutes only about 0.25% of total T3 in circulation.

• T3 measurements on top of T4/FT4 helps to confirm hyperthyroidism diagnosis.

• Abnormal elevations of total T3 may occur when total T4 conc. is normal- “T3- toxicosis”

• But we see that Free T3 correlates more closely with the actual thyroid status of the patient than total T3.

Page 45: Thyroid hormones: Clinical and Biochemical Insight

Impact of Drugs on Thyroid Hormone Levels

Page 46: Thyroid hormones: Clinical and Biochemical Insight
Page 47: Thyroid hormones: Clinical and Biochemical Insight

Facial Features in Hypothyroidism

Page 48: Thyroid hormones: Clinical and Biochemical Insight

See the differences after successful therapy

Page 49: Thyroid hormones: Clinical and Biochemical Insight

Facial Features in Hyperthyroidism

• Opthalmopathy in Grave’s Disease• Lid retraction

• Periorbital edema

• Conjunctival injection

• Proptosis

Page 50: Thyroid hormones: Clinical and Biochemical Insight

Thyroid Dermopathy over lateral aspects of the shins.Thyroid Acropachy

Page 51: Thyroid hormones: Clinical and Biochemical Insight

THANK YOU


Recommended